Skip to content
10-Q

Quarterly Report

Odonate Therapeutics, Inc.

0001564590-21-056269

← back to feed
Filed
Nov 10, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Oct 29, 2021 38.49M sh
Stock Issued Q3 2021 · Sep 30, 2021 842.11K sh
Stock Issued Q3 2021 · Sep 1, 2020 5.61M sh
Capex Q3 2021 · Sep 30, 2021 $26K
Capex Q3 2021 · Sep 30, 2020 $416K
Operating Cash Flow Q3 2021 · Sep 30, 2021 −$63.04M
Operating Cash Flow Q3 2021 · Sep 30, 2020 −$81.63M
Cash And Equivalents Q3 2021 · Sep 30, 2021 $95.74M
Cash And Equivalents Q3 2021 · Dec 31, 2020 $157.98M
Cash And Equivalents Q3 2021 · Sep 30, 2020 $188.97M
Cash And Equivalents Q3 2021 · Dec 31, 2019 $181.17M
Stockholders Equity Q3 2021 · Sep 30, 2021 $71.37M
Stockholders Equity Q3 2021 · Jun 30, 2021 $84.63M
Stockholders Equity Q3 2021 · Mar 31, 2021 $105.3M
Stockholders Equity Q3 2021 · Dec 31, 2020 $136.15M
Stockholders Equity Q3 2021 · Sep 30, 2020 $165.6M
Stockholders Equity Q3 2021 · Jun 30, 2020 $105.55M
Stockholders Equity Q3 2021 · Mar 31, 2020 $135.24M
Stockholders Equity Q3 2021 · Dec 31, 2019 $162.3M
Current Liabilities Q3 2021 · Sep 30, 2021 $30.3M
Current Liabilities Q3 2021 · Dec 31, 2020 $27.07M
Total Liabilities Q3 2021 · Sep 30, 2021 $34.4M
Total Liabilities Q3 2021 · Dec 31, 2020 $31.74M
Current Assets Q3 2021 · Sep 30, 2021 $99.58M
Current Assets Q3 2021 · Dec 31, 2020 $159.87M
Total Assets Q3 2021 · Sep 30, 2021 $105.77M
Total Assets Q3 2021 · Dec 31, 2020 $167.89M
Sga Expense Q3 2021 · Sep 30, 2021 $11.15M
Sga Expense Q3 2021 · Sep 30, 2021 $17.47M
Sga Expense Q3 2021 · Sep 30, 2020 $2.41M
Sga Expense Q3 2021 · Sep 30, 2020 $8.03M
Rd Expense Q3 2021 · Sep 30, 2021 $2.87M
Rd Expense Q3 2021 · Sep 30, 2021 $52.42M
Rd Expense Q3 2021 · Sep 30, 2020 $28.24M
Rd Expense Q3 2021 · Sep 30, 2020 $86.97M
Net Income Q3 2021 · Sep 30, 2021 −$14M
Net Income Q3 2021 · Sep 30, 2021 −$69.78M
Net Income Q3 2021 · Jun 30, 2021 −$22.02M
Net Income Q3 2021 · Mar 31, 2021 −$33.77M
Net Income Q3 2021 · Sep 30, 2020 −$30.48M
Net Income Q3 2021 · Sep 30, 2020 −$94.06M
Net Income Q3 2021 · Jun 30, 2020 −$33.42M
Net Income Q3 2021 · Mar 31, 2020 −$30.16M
Operating Income Q3 2021 · Sep 30, 2021 −$14.02M
Operating Income Q3 2021 · Sep 30, 2021 −$69.89M
Operating Income Q3 2021 · Sep 30, 2020 −$30.65M
Operating Income Q3 2021 · Sep 30, 2020 −$95M